SO
MBX

STRS Ohio’s MBX Biosciences MBX Stock Holding History

STRS Ohio’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.8K Buy
1,600
+900
+129% +$30.6K ﹤0.01% 1942
2025
Q4 		$22.1K Hold
700
– – ﹤0.01% 2100
2025
Q3 		$12.3K Hold
700
– – ﹤0.01% 2144
2025
Q2 		$7.99K Hold
700
– – ﹤0.01% 2171
2025
Q1 		$5.17K Sell
700
-1,400
-67% -$14.8K ﹤0.01% 1895
2024
Q4 		$38.7K Buy
+2,100
New +$44.8K ﹤0.01% 1756

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

STRS Ohio's MBX Position: Q1 2026 in Review

STRS Ohio increased its MBX Biosciences (MBX) stake by 129% in Q1 2026, buying an estimated $30.6K and bringing the position to 1,600 shares worth $47.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1942.

STRS Ohio first reported a position in MBX in Q4 2024 and has held it in 6 quarters since. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • STRS Ohio held 1,600 shares of MBX Biosciences worth $47.8K as of Q1 2026.
  • STRS Ohio bought 900 MBX Biosciences shares in Q1 2026, an estimated $30.6K.
  • MBX Biosciences made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1942 holding.
  • STRS Ohio first reported a position in MBX Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.